申请人:Sandoz Ltd.
公开号:US04622336A1
公开(公告)日:1986-11-11
3,3-Dialkyl- or 3,3-alkylene-indolines which are unsubstituted at the 1- and 2-positions and which are substituted at the 4- or 6-position by an optionally etherified hydroxy group or substituted at the 5- or 7-position by an etherified hydroxy group, as well as their physiologically-hydrolyzable and -acceptable esters. The said indolines and esters as well as their pharmaceutically acceptable acid addition salts possess analgesic activity.
3,3-二烷基或3,3-烷基-吲哚啉,在1-和2-位未被取代,在4-或6-位被取代为可选醚化羟基,或在5-或7-位被醚化羟基取代,以及它们的生理可水解和可接受的酯类。所述的吲哚啉和酯类以及它们的药学上可接受的酸加成盐具有镇痛活性。